OpenURL Connection Search

Select item for more details and to access through your institution.

Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.
Published in:
2014
By:
- Crose, Lisa E S;
- Galindo, Kathleen A;
- Kephart, Julie Grondin;
- Chen, Candy;
- Fitamant, Julien;
- Bardeesy, Nabeel;
- Bentley, Rex C;
- Galindo, Rene L;
- Ashley Chi, Jen-Tsan;
- Linardic, Corinne M;
- Chi, Jen-Tsan Ashley
Publication type:
journal article
Alveolar rhabdomyosarcoma-associated PAX3-FOX01 promotes tumorigenesis via Hippo pathway suppression.
Published in:
Journal of Clinical Investigation, 2014, v. 124, n. 1, p. 285, doi. 10.1172/JCI67087
By:
- Crose, Lisa E.S.;
- Galindo, Kathleen A.;
- Kephart, Julie Grondin;
- Chen, Candy;
- Fitamant, Julien;
- Bardeesy, Nabeel;
- Bentley, Rex C.;
- Galindo, Rene L.;
- Chi, Jen-Tsan Ashley;
- Linardic, Corinne M.
Publication type:
Article
Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting.
Published in:
2012
By:
- Belyea, Brian;
- Grondin Kephart, Julie;
- Blum, Jordan;
- Kirsch, David G.;
- Linardic, Corinne M.
Publication type:
Journal Article
Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting.
Published in:
Sarcoma, 2012, p. 1, doi. 10.1155/2012/406239
By:
- Belyea, Brian;
- Grondin Kephart, Julie;
- Blum, Jordan;
- Kirsch, David G.;
- Linardic, Corinne M.
Publication type:
Article
Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.
Published in:
Prostate, 2017, v. 77, n. 4, p. 385, doi. 10.1002/pros.23277
By:
- Armstrong, Andrew J.;
- Humeniuk, Michael S.;
- Healy, Patrick;
- Szmulewitz, Russell;
- Winters, Carolyn;
- Kephart, Julie;
- Harrison, Michael R.;
- Martinez, Elia;
- Mundy, Kelly;
- Halabi, Susan;
- George, Daniel
Publication type:
Article
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Published in:
Prostate, 2022, v. 82, n. 7, p. 858, doi. 10.1002/pros.24329
By:
- Tian Zhang;
- Kephart, Julie;
- Bronson, Elizabeth;
- Anand, Monika;
- Daly, Christine;
- Spasojevic, Ivan;
- Bakthavatsalam, Subha;
- Franz, Katherine;
- Berg, Hannah;
- Karachaliou, Georgia S.;
- James, Olga G.;
- Howard, Lauren;
- Halabi, Susan;
- Harrison, Michael R.;
- Armstrong, Andrew J.;
- George, Daniel J.
Publication type:
Article
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer.
Published in:
Cancer (0008543X), 2021, v. 127, n. 16, p. 2954, doi. 10.1002/cncr.33589
By:
- George, Daniel J.;
- Halabi, Susan;
- Heath, Elisabeth I.;
- Sartor, A. Oliver;
- Sonpavde, Guru P.;
- Das, Devika;
- Bitting, Rhonda L.;
- Berry, William;
- Healy, Patrick;
- Anand, Monika;
- Winters, Carol;
- Riggan, Colleen;
- Kephart, Julie;
- Wilder, Rhonda;
- Shobe, Kellie;
- Rasmussen, Julia;
- Milowsky, Matthew I.;
- Fleming, Mark T.;
- Bearden, James;
- Goodman, Michael
Publication type:
Article

Found: 7

Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression.

Alveolar rhabdomyosarcoma-associated PAX3-FOX01 promotes tumorigenesis via Hippo pathway suppression.

Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting.

Embryonic Signaling Pathways and Rhabdomyosarcoma: Contributions to Cancer Development and Opportunities for Therapeutic Targeting.

Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.

Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.

A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate‐resistant prostate cancer.